Literature DB >> 10434539

[Erythema multiforme. A heterogeneous pathologic phenotype].

M Carrozzo1, M Togliatto, S Gandolfo.   

Abstract

The term Erythema Multiforme (EM) include actually a wide range of clinical expressions, from exclusive oral erosions (Oral EM) to mucocutaneous lesions (EM Minor), sometimes with severe involvement of multiple mucosal membrane (EM major, Stevens-Johnson syndrome [SJS]) or with involvement of a large area of the total body surface (toxic epidermal necrolysis [TEN]). However, this terminology is not worldwide accepted and often the various clinical categories show some overlapping features. Among the great number of suspected etiological factors, herpes simplex virus is involved in many cases of EM minor whereas SJS and TEN are caused in 80% of cases by systemic drugs, mainly by anticonvulsivants, sulfonamides, nonsteroidal anti-inflammatory drugs and antibiotics. Several oral EM seem idiopathic, but data on this topic are very few. There is no specific or consistent microscopic and immunopathologic pattern of EM and the diagnosis should be done by excluding other similar diseases. The treatment include the use of antivirals for EM minor, mainly if recurrent, and of immunosuppressants (especially systemic corticosteroids) for SJS. TEN patients require adequate supportive care and often they have to be treated in emergency departments. Finally, patients with exclusive oral lesions may be treated with both topical and systemical corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434539

Source DB:  PubMed          Journal:  Minerva Stomatol        ISSN: 0026-4970


  3 in total

1.  A rare thymoma case with seven paraneoplastic syndromes.

Authors:  Li Gong; Pei Zhang; Xue-Yuan Liu; Min Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

3.  Treatment of recurrent erythema multiforme with adalimumab as monotherapy.

Authors:  Bryan Baillis; John C Maize
Journal:  JAAD Case Rep       Date:  2017-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.